Dr Reddys Laboratories (RDY) EBT Margin (2009 - 2026)
Dr Reddys Laboratories (RDY) recorded EBT Margin of 6.85% in the quarter ended Jun 30, 2026, down 15.44 percentage points from 22.29% a year earlier but up 4.20 percentage points from the prior quarter.
Dr Reddys Laboratories (RDY) EBT Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Dr Reddys Laboratories' EBT Margin came in at 12.66% as of Jun 30, 2026, down 10.38 percentage points year-over-year; for the year ended Mar 31, 2026, it came in at 16.31%, down 7.28 percentage points from the prior year.
- Annual EBT Margin has a five-year change of +2.40 percentage points (years ended Mar 2021 to Mar 2026).
- Across earlier years, EBT Margin came in at 23.59% in the year ended Mar 31, 2025 (-2.14 pp), 25.73% in the year ended Mar 31, 2024 (+1.20 pp), 24.53% in the year ended Mar 31, 2023 (+9.46 pp) and 15.07% in the year ended Mar 31, 2022 (+1.16 pp).
- Quarterly EBT Margin has ranged from 2.65% in the quarter ended Mar 31, 2026 to 28.10% in the quarter ended Jun 30, 2022 over the past five years.
- On a year-over-year basis, EBT Margin has declined for five consecutive quarters, with an average year-over-year change of -6.53 percentage points over the last eight quarters.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 22.81 percentage points in the quarter ended Mar 31, 2023, against a drop of 20.93 percentage points in the quarter ended Mar 31, 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at 2.65% (quarter ended Mar 31, 2026), 17.68% (quarter ended Dec 31, 2025) and 20.84% (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 41.75% |
| 10 | Dr Reddys Laboratories | 10.73 Bn | 9.91 Bn | 396.53 Mn | 6.85% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.85% |
| Mar 31, 2026 | 2.65% |
| Dec 31, 2025 | 17.68% |
| Sep 30, 2025 | 20.84% |
| Jun 30, 2025 | 22.29% |
| Mar 31, 2025 | 23.58% |
| Dec 31, 2024 | 22.42% |
| Sep 30, 2024 | 23.91% |
| Jun 30, 2024 | 24.53% |
| Mar 31, 2024 | 22.61% |
| Dec 31, 2023 | 25.30% |
| Sep 30, 2023 | 27.81% |
| Jun 30, 2023 | 27.78% |
| Mar 31, 2023 | 27.37% |
| Dec 31, 2022 | 21.12% |
| Sep 30, 2022 | 24.15% |
| Jun 30, 2022 | 28.10% |
| Mar 31, 2022 | 4.57% |
| Dec 31, 2021 | 11.30% |
| Sep 30, 2021 | 18.26% |
Dr Reddys Laboratories EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();